Medicare Enrolled

Dr. Vidal Primiterio, PA

Medical Physician Assistant · Lawrence, MA
Low-engagement
25 MARSTON ST, Lawrence, MA 01841
9782581057
In practice since 2006 (20 years)
NPI: 1861472987 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Primiterio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Primiterio? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Primiterio

Dr. Vidal Primiterio is a medical physician assistant in Lawrence, MA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Primiterio received a total of $17,396 from 45 pharmaceutical and/or device companies across 848 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Primiterio is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $17,396 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$17,396
Total received (2021-2024)
Avg $4,349/year across 4 years
Top 1% in MA for medical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
848
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,123 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$273 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,227
2023
$4,723
2022
$4,306
2021
$4,140

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$504
PFIZER INC.
$441
ABBVIE INC.
$420
Bayer Healthcare Pharmaceuticals Inc.
$281
Novo Nordisk Inc
$265
Phathom Pharmaceuticals, Inc.
$227
GlaxoSmithKline, LLC.
$211
Astellas Pharma US Inc
$208
Amgen Inc.
$197
Janssen Pharmaceuticals, Inc
$172
SHIELD THERAPEUTICS INC
$171
Ardelyx, Inc.
$160
Abbott Laboratories
$159
Otsuka America Pharmaceutical, Inc.
$147
Exact Sciences Corporation
$104
E.R. Squibb & Sons, L.L.C.
$102
Lundbeck LLC
$77
Sumitomo Pharma America, Inc.
$68
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$50
Inspire Medical Systems, Inc.
$48
ViiV Healthcare Company
$45
Lilly USA, LLC
$43
Xeris Pharmaceuticals, Inc.
$40
QOL Medical, LLC
$34
Top 3 companies account for 32.3% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$2,287
ABBVIE INC.
$1,520
PFIZER INC.
$1,297
Amgen Inc.
$1,131
Novo Nordisk Inc
$1,122
Janssen Pharmaceuticals, Inc
$980
GlaxoSmithKline, LLC.
$861
AbbVie Inc.
$674
Lilly USA, LLC
$602
Astellas Pharma US Inc
$541
Bayer Healthcare Pharmaceuticals Inc.
$529
Novartis Pharmaceuticals Corporation
$475
Biohaven Pharmaceuticals, Inc.
$421
RedHill Biopharma Inc.
$415
Merck Sharp & Dohme LLC
$381
Boehringer Ingelheim Pharmaceuticals, Inc.
$327
SANOFI-AVENTIS U.S. LLC
$315
Sumitomo Pharma America, Inc.
$292
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$267
Phathom Pharmaceuticals, Inc.
$227
Exact Sciences Corporation
$219
Abbott Laboratories
$195
Ardelyx, Inc.
$190
Otsuka America Pharmaceutical, Inc.
$183
Paratek Pharmaceuticals, Inc.
$179
Esperion Therapeutics, Inc.
$179
Biohaven Pharmaceutical Holding Company Ltd.
$176
SHIELD THERAPEUTICS INC
$171
Bayer HealthCare Pharmaceuticals Inc.
$147
E.R. Squibb & Sons, L.L.C.
$135
Nestle HealthCare Nutrition Inc.
$127
Merck Sharp & Dohme Corporation
$117
Lundbeck LLC
$100
ViiV Healthcare Company
$97
Xeris Pharmaceuticals, Inc.
$80
Shield Therapeutics Inc
$79
Takeda Pharmaceuticals U.S.A., Inc.
$53
Inspire Medical Systems, Inc.
$48
Teva Pharmaceuticals USA, Inc.
$46
Dexcom, Inc.
$45
Ironwood Pharmaceuticals, Inc
$40
Genentech USA, Inc.
$40
Amarin Pharma Inc.
$34
QOL Medical, LLC
$34
IDORSIA PHARMACEUTICALS US INC
$16
Top 3 companies account for 29.3% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AJOVY · AREXVY · Aimovig · BELSOMRA · BREZTRI · BRILINTA · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Cologuard Collection Kit · DOVATO · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · GEMTESA · GVOKE HYPOPEN · IBSRELA · INSPIRE · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LYUMJEV · Linzess · MOTEGRITY · MOUNJARO · MYCAMINE · MYRBETRIQ · Movantik · Myrbetriq · NEXLETOL · NURTEC ODT · NUZYRA · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUCRAID · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Talicia · UBRELVY · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · XARELTO · XIFAXAN · Xofluza · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for medical physician assistant in MA.

Looking for a medical physician assistant in Lawrence?
Compare medical physician assistants in the Lawrence area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical physician assistants within 10 mi
236
Per 100K population
29.2
County median income
$99,431
Nearest hospital
HOLY FAMILY HOSPITAL
2.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Primiterio is a medical physician assistant, with low-engagement industry engagement in the top 1% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Primiterio receive payments from pharmaceutical companies?
Yes. Dr. Primiterio received a total of $17,396 from 45 companies across 848 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Primiterio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →